Aaron C.W. Lasker, MD
Assistant Professor of Clinical Neurology
Director, HDSA Huntington's Disease Center of Excellence, University of Pennsylvania
Department: Neurology
Contact information
330 S 9th Street
3rd floor
Philadelphia, PA 19107
3rd floor
Philadelphia, PA 19107
Office: 215.829.6500
Fax: 215.829.6606
Fax: 215.829.6606
Links
University of Pennsylvania Huntington's Disease Center, Director
Interview regarding Parkinson's disease and palliative care
University of Pennsylvania Huntington's Disease Center, Director
Interview regarding Parkinson's disease and palliative care
Education:
B.Sc (Neuroscience)
Brown University, Providence, RI, 2007.
MD (Neurology)
Tufts University School of Medicine, Boston, MA, 2013.
B.Sc (Neuroscience)
Brown University, Providence, RI, 2007.
MD (Neurology)
Tufts University School of Medicine, Boston, MA, 2013.
Post-Graduate Training
Internship for Internal Medicine, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, 2013-2014.
Residency in Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center, Boston, MA, 2014-2017.
Fellowship in Cognitive Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Fellowship in Movement Disorders, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Internship for Internal Medicine, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, 2013-2014.
Residency in Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center, Boston, MA, 2014-2017.
Fellowship in Cognitive Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Fellowship in Movement Disorders, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Certifications
American Board of Psychiatry and Neurology, Board Certified Neurologist , 2017.
Permanent linkAmerican Board of Psychiatry and Neurology, Board Certified Neurologist , 2017.
Description of Clinical Expertise
Movement Disorders Specialist with an interest in Huntington's disease and Parkinson's disease. Special interest in cognition, non-motor symptoms and neuropalliative care. clinical administration of botulinum toxin injections.Selected Publications
Carly Marshall MD, Jennifer Klapper RN, Paul Cinicola BA, Whitley Aamodt MD, Aaron Lasker MD. : Feasibility and Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic. Movement Disorders Society, Annual Congress 2024 – Philadelphia PA September 2024.Alice Chen-Plotkin, Thomas Tropea, Whitney Hartstone, Noor Amari, Dylan Baum, Jacqueline Rick, EunRan Suh, Hanwen Zhang, Rachel Paul, Noah Han, Rebecca Zack, Eliza Brody, Isabela Albuja, Justin James, Meredith Spindler, Andres Deik, Whitley Aamodt, Nabila Dahodwala, Ali Hamedani, Aaron Lasker, Howard Hurtig, Matthew Stern, Daniel Weintraub, Pavan Vaswani, Allison Willis, Andrew Siderowf, Sharon Xie, and Vivianna Van Deerlin: Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level. npj Parkinson's Disease May 2024.
Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA: Disparities in Genetic Testing for Neurologic Disorders. Neurology March 2024.
Laynie Dratch, Meron Azage, Aaron Baldwin, Kelsey Johnson, Rachel A. Paul, Tanya M. Bardakjian, Sara‑Claude Michon, Defne A. Amado, Michael Baer, Andres F. Deik, Lauren B. Elman, Pedro Gonzalez‑Alegre, Michael H. Guo, Ali G. Hamedani, David J. Irwin, Aaron Lasker, Jennifer Orthmann‑Murphy, Colin Quinn, Thomas F. Tropea, Steven S. Scherer, Colin A. Ellis: Genetic Testing in Adults with neurologic disorders: indications, approach, and clinical impacts. Journal of Neurology February 2024 Notes: Epub 2023 Oct 27.
Andres Deik, Meredith Spindler, Aaron Lasker, Pavan Vaswani, Whitley Aamodt, Thomas Tropea. : A phase I/II open-label study to define the safety, tolerability and clinical activity of deutetrabenazine (AUstedo) in adult study subjects with DYsTonia (the AUDYT trial). PAS Congress 2024 in Cartagena, Colombia February 2024.
ALLAN COLE: Parkinson's and Palliative care. PDwise.com February 2022.
A Shaji, N Ko, M Solanki, Y Ocasio, P Kaur, E Muller, A Mendez, A Lasker: Mindfulness Based Program for Newly Diagnosed Parkinson’s Patients. Movement Disorders Society, 2022, Annual Congress - Madrid 2022.
A Shaji, N Ko, M Solanki, Y Ocasio, P Kaur, E Muller, A Mendez, A Lasker: Mindfulness Based Program for Newly Diagnosed Parkinson’s Patients. American Neurological Association, 2022 Annual Meeting 2022.
C. Ashton, C Tacci, R Laracuente, E Sorberg, L Solis-Cohen, S Horn, A Lasker, V Vanderhorst and L Shih.: Spatio-temporal Analysis and Modeling of Gait in Parkinson’s Disease. American Neurological Association, Annual Meeting 2016 Notes: Lecturer and power-point slide developer.
Kitsios GD, Lasker A, Singh J, Thaler DE.: Recurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysis. Neurology 8(13): 993-997, Mar 27 2012.